# ZYPREXA RELPREVV
> **NDA022173** · New Drug Application · Sponsor: CHEPLAPHARM · Approved 2009-12-11
## Drug
- **FDA Application Number:** NDA022173
- **Application type:** New Drug Application
- **Brand name:** ZYPREXA RELPREVV
- **Generic name:** OLANZAPINE PAMOATE
- **Active ingredients:** OLANZAPINE PAMOATE
- **Dosage form:** SUSPENSION, EXTENDED RELEASE
- **Route:** INTRAMUSCULAR
- **Marketing status:** Prescription
- **Sponsor:** CHEPLAPHARM
- **Manufacturer:** H2-Pharma LLC
- **First approval:** 2009-12-11
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022173)
---
*AI Analytics · CC0 1.0*